Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCA for Actinic Cheilitis
NCT04744103Phase 4Withdrawn
- Sponsor
- Nova Scotia Health
- Start
- Sep 2023
- Primary completion
- Sep 2023
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of trichloroacetic acid in actinic cheilitis (AC), sponsored by Nova Scotia Health. Planned start Sep 2023; status: withdrawn.
02
Drugs
trichloroacetic acid
03
Conditions
actinic cheilitis (AC)
Beyond the preview
Go deeper on NCT04744103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04744103.